Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Halitosis originates from an oral or a non-oral source. It is caused by volatile molecules, which are developed due to pathological or non-pathological reasons. These volatile compounds are aromatic compounds, sulphur compounds, short-chain fatty acids, nitrogen-containing compounds, amines, aliphatic compounds, alcohols or phenyl compounds, and ketones.
Various causes of halitosis include cancer of the larynx, nasopharyngeal abscess, and lower respiratory tract infections such as asthma, bronchiectasis, chronic bronchitis, bronchiectasis, lung abscess, cystic fibrosis, interstitial lung diseases, and pneumonia. According to the International Journal of Oral Science 2012 study, around 10% of the oral malodor cases originate from the ears, nose and throat region, and 3% of it occur due to tonsils.
Market Dynamics
Increasing consumption of tobacco and alcohol, medical condition such as tonsils and inflammation of nose, throat or sinuses and metabolic diseases are the major factors driving the halitosis treatment market growth. According to the National Center for Biotechnology Information (NCBI) 2013 study, halitosis is very common and affects around 50% of the general population around the world.
Although halitosis has multifactorial origins, around 90% cases occur due to oral cavity such as poor oral hygiene, tongue coat, periodontal disease, unclean dentures, food impaction, oral carcinomas, faulty restorations, and throat infections. Treatment of halitosis is very important, as it can cause serious conditions such as stress. According to the Bad Breath Institute 2018 study, people with halitosis are 60% more likely to suffer from stress, while 57% of bad breath sufferers report feelings of depression due to their condition. However, lack of awareness among the under developed regions can confine the halitosis treatment market growth.
Key features of the study:
This report provides in-depth analysis of the halitosis treatment market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global halitosis treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Abbott Laboratories, AstraZeneca Plc, Colgate-Palmolive Company, Dr. Harold Katz, Listerine, and Rowpar Pharmaceuticals
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global halitosis treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for halitosis treatment market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Halitosis Treatment Market, By Type:
Pathological
Non-pathological
Global Halitosis Treatment Market, By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Global Halitosis Treatment Market, By Region:
North America
By Country:
U.S.
Canada
By Type:
Pathological
Non-pathological
By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Type:
Pathological
Non-pathological
By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Type:
Pathological
Non-pathological
By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Type:
Pathological
Non-pathological
By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type:
Pathological
Non-pathological
By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Type:
Pathological
Non-pathological
By Treatment:
Antacids
Antiseptics
Antiplaque
Others
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AstraZeneca Plc
Colgate-Palmolive Company
Harold Katz
Listerine
Rowpar Pharmaceuticals
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Type
o Market Snippet, By Treatment
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Epidemiology Analysis
o PORTER'S Five Forces
4. Global Halitosis Treatment Market, By Type, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Pathological
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Non-pathological
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Halitosis Treatment Market, By Treatment, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Antacids
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Antiseptics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Antiplaque
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Halitosis Treatment Market, By Region, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o AstraZeneca Plc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Colgate-Palmolive Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Dr. Harold Katz
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Listerine
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Rowpar Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 19 market data tables and 23 figures on "Halitosis Treatment Market" - Global forecast to 2026".
